Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Cadila Healthcare to sell stake in Windlas Healthcare to Windlas Biotech for Rs 99.44 cr
The sale is expected to be completed within 10 business days
Pharma supply chain disruptions following Covid-19 outbreak eases; sector outlook revised to stable…
The global demand is largely expected to be stable for the industry owing to the inelastic nature of prescription drugs though…
CSIR identifies top 25 drugs/drug candidates for repurposing
Favipiravir, a broad-spectrum inhibitor of viral RNA polymerase, emerges as one of the most promising drugs
Favipiravir exports during COVID-19 outbreak reaffirm India’s position as Pharmacy to the World:…
Favipiravir is the fourth most evaluated repurposed drug after HCQ, lopinavir/ritonavir combination, and recombinant interferon…
Pharma workforce post COVID-19
Experts share some of the most immediate and important changes that will be reflected in the pharma workforce and its management…
SNBNCBS develops nanomedicine for better immune power to treat viral infections
It alters oxidative stress in the body to aid immune cells to perform their natural functions more efficiently
Pharma sector requests time-bound relief in DPCO list citing APIs price rise
The prices of APIs used in hand sanitisers have also jumped significantly
DuPont’s XIVIA Xylitol demonstrates positive effects on skin microbial growth
Xylitol is utilized due to its hydrating properties within skin care products, and the research is showing interesting abilities…
‘This crisis has not only brought into focus the urgency but also the sheer need of partnering’
Gilles Toulemonde, CEO at Inova Software decodes how the life sciences industry can accelerate partnering against COVID-19 in an…
Premas Biotech announces development of vaccine against COVID-19
The triple antigen vaccine being developed by Premas Biotech is being designed to try to overcome presently known and possible…